pityriasis%20(tinea)%20versicolor
PITYRIASIS (TINEA) VERSICOLOR
Pityriasis (Tinea) versicolor is a fungal infection caused by Malassezia furfur. It is benign, superficial, and localized to the stratum corneum.
It may present as chronic or recurrent infection and may occur in healthy individuals.
It is more common in summer than winter months.
It presents with multiple well-demarcated macules or patches and finely scaled plaques with hypopigmentation or hyperpigmentation, hence the term "versicolor".
Lesions are usually found on the upper trunk, chest, back and shoulders, and may extend toward the neck, face and arms.

Pityriasis (Tinea) Versicolor Drug Information

Drug Information

Indication: Cryptococcosis. Systemic, mucosal & vag candidiasis. Prevention of fungal infection in patients w/ maligna...

Indication: Topical treatment of tinea pedis, tinea cruris, tinea corporis, tinea versicolor, erythrasma candidiasis due t...

Indication: Ear drops: Otomycosis. Prophylaxis for swimmers. Lotion: Tinea capitis, tinea barbae, tinea unguium, tinea cor...

Indication: Fungal skin infections eg, athlete's foot, white spots, ringworm, tissues adjacent to nails, skin folds; eryth...

Indication: Topical fungal infection caused by dermatophytes, yeast, moulds & other fungi including Tinea infections, ...

Indication: Fungal skin infections due to dermatophytes & other dermal infections eg, Tinea pedis, cruris & corpor...

Indication: Topical fungal infection caused by dermatophytes, yeast infection, pityriasis versicolour & cutaneous cand...

Indication: Tinea pedia, tinea cruris & tinea corporis, cutaneous candidiasis & tinea versicolor.

Indication: Topical treatment of tinea corporis, tinea cruris, tinea pedis, pityriasis versicolor & cutaneous candidiasis.

Dezor Plus
ketoconazole + zinc pyrithione

Indication: Topical treatment of seborrheic scalp dermatitis & dandruff.

2  /  9
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
16 Jan 2021
Diagnosis of heart diseases has abruptly and significantly decreased across the globe due to the coronavirus disease 2019 (COVID-19) pandemic, especially affecting poorer countries, reveals a study.
Roshini Claire Anthony, 01 Dec 2020

An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.

Pearl Toh, Yesterday
While it is well known that COVID-19 illness is associated with coagulopathy, the optimal anticoagulation strategy remains elusive, and two studies presented at the ASH 2020 Congress further add to the growing debate on the appropriate anticoagulant dose for hospitalized patients with COVID-19.